Pancreatic cancer vaccine shows promise

Can mRNA vaccines help in the fight against pancreatic cancer?
There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target and reduce malignant tumors. NBC News medical contributor Dr. Kavita Patel reports on the vaccine’s success against pancreatic cancer,
Vaccine shows promise for treating pancreatic cancer, study shows
A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study published in the journal Nature.
A Vaccine For Pancreatic Cancer Continues To Show Promise
In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three years later.
mRNA vaccines show promise against pancreatic cancer in early trial
Personalized mRNA vaccines show promise as a pancreatic cancer treatment, according to a small, early stage trial published Wednesday.
Vaccine targeting pancreatic cancer shows promise in new study of clinical trial
A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage pancreatic cancer patients.
Trial shows promise of mRNA vaccines in treating pancreatic cancer
The phase 1 trial results, published Feb. 19 in Nature, evaluated the personalized mRNA neoantigen vaccine autogene cevumeran in combination with surgery, immunotherapy drug atezolizumab and chemotherapy in patients with pancreatic ductal adenocarcinoma.
Vaccine Shows Promise for Pancreatic Cancer, Study Finds
In a small trial, 8 of 16 patients responded well to the mRNA vaccine The vaccine is personalized, based on each patient’s tumor Larger trials are underway to confirm the vaccine’s role in preventing
Can You Personalize Your Pancreatic Cancer Vaccinations?
As per a new study, the potential of mRNA vaccines offers a personalized treatment for patients with pancreatic cancer.
New mRNA vaccine shows promise against pancreatic cancer, may extend life by 10 years
In a significant development for pancreatic cancer treatment, a phase 1 clinical trial has highlighted the potential of personalized mRNA vaccines to treat the deadly disease. This research comes at a critical time,
Experimental vaccine for common cancer shows potential in clinical trial
A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...
The Daily Pennsylvanian4d
Here’s how Penn researchers are using mRNA technology to treat cancer, celiac disease
Penn researchers are developing new treatments using mRNA technology to combat a range of diseases, namely celiac disease ...
Analyst Confident In Moderna's Cancer Vaccine But Highlights Other Challenges
EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...
Cancer vaccine for women to be available in six months; check details
The vaccine will be administered to girls between the ages of nine and 16 as part of the government’s initiative to address the rising number of cancer cases in the country.
Life-Saving Cancer Vaccine for Women Expected Within 6 Months
Union Minister Prataprao Jadhav said vaccine to fight cancers affecting women will be available in five to six months. Read ...
Montana seeks to ban mRNA shots as vaccine hesitancy soars
Health Secretary Robert F. Kennedy Jr. is a noted vaccine skeptic, and President Donald Trump has expressed concerns about ...
CureVac's SWOT analysis: mRNA pioneer's stock faces pivotal year in vaccine race
CureVac N.V. (NASDAQ:CVAC), a biopharmaceutical company specializing in mRNA-based therapies and vaccines with a market ...
Scientific American5d
A Vaccine for the Dreaded Norovirus Is Closer Than Ever
Norovirus infection rates are extremely high this year, raising the question: Why can’t a vaccine protect us from the stomach ...